Inhibition of RIPK 1 expression and facilitation of TRAIL-induced hepatocellular carcinoma cell apoptosis by miR-141

Minjie Shang,Defei Hong,Zhiming Hu,Chengwu Zhang,Weiding Wu

2017-01-01

Abstract:Receptor-interacting protein kinase 1 (RIPK1) activates NF-κB and facilitates cell survival under tumor necrosis factor related apoptosis inducing ligand (TRAIL) induction, thus negatively regulating cell apoptosis but leaving detailed mechanism unclear. Previous study showed depressed expression of microRNA (miR)-141 in hepatocellular carcinoma (HCC) patients. Bioinformatics analysis showed satisfactory targeted relationship between miR-141 and 3’-UTR of RIPK1. This study thus investigated the role of miR-141 and RIPK1 expressional dysregulation in HCC cell apoptosis. Rat HCC model was generated to test miR-141 and RIPK1 expression. HCC patients were recruited to compare expression levels between HCC and adjacent tissues. Dual luciferase reporter assay substantiated targeting relationship between miR-141 and RIPK1. Cultured HepG2 cells were treated with 80 ng/mL TRAIL, miR-141 mimic and/or si-RIPK1. Caspase-3 activity was measured in addition to flow cytometry for cell apoptosis, plus CCK-8 assay for proliferative activity. Western blot was used to test transcriptional activity of RIPK1 and NF-κB proteins. Rat HCC tissue had lower miR-141 and higher RIPK1 expression, as those in HCC patients. MiR-141 targeted 3’-UTR of RIPK1 and inhibited its expression. TRAIL up-regulated RIKP1 expression in HepG2 cells. Elevation of miR-141 and/or silencing RIPK1 inhibited TRAIL-induced NF-κB transcriptional activation, weakened cell proliferative activity, potentiated caspase-3 activity and facilitated cell apoptosis. MiR-141 targeted and inhibited RIPK1, inhibited TRAIL-induced NF-κB transcriptional activation in HepG2 cells, and facilitated TRAIL-induced caspase-3 activation and apoptosis.